Cancer · World
Cancer · World · 18 stories in 48h · Clear all filters
- Seeking Alpha GSK wins FDA nod for lung cancer therapy added from Nuvalent buyout
- Nasdaq.com MAIA Biotechnology Reports Consistent Strong Efficacy in Expanded Phase 2 THIO-101 Study in Non-Small Cell Lung CancerMAIA Biotechnology, Inc. announced updated interim efficacy data from Part C of its Phase 2 THIO-101 expansion trial…
-
My family history of cancer was giving me so much anxiety. I finally learned to stop turning to Dr. Google.Every medical test triggered my fear of cancer, and searching my symptoms online made it worse. I had…
- Nasdaq.com Axe Compute Inc. Reports Third Quarter 2026 Financial ResultsPredictive Oncology Inc. (operating as Axe Compute Inc.) reported its financial results for the third quarter ended September…
- Seeking Alpha Lilly inks oncology licensing deal worth up to $5.9B with Stipple Bio
-
Raymond James reiterates Strong Buy on Aktis Oncology stock at $40
-
I founded a cancer biotech company. Then, my mom, dad, and I were all diagnosed with cancer.Dr. Ryan Beal is the CEO of Dyve, a cancer-biotech company. He, his dad, and his mom have…
-
Pancreatic cancer mystery deepens as researchers make unexpected discoveryUniversity of Cincinnati study found Black patients' pancreatic tumors had more B cells and cells tied to drug…
-
Roche gets FDA approval for advanced breast cancer pill
-
RBC Capital downgrades CG Oncology stock rating on regulatory path
-
Reuters
US FDA approves Roche's oral treatment for advanced breast cancer
-
The FDA declined to approve one of biotech’s most closely watched cancer drugsThe regulator told Summit Therapeutics that the lung-cancer drug needs to prove it can help people live longer.
-
Bloomberg
William and Kate Begin India Tour With Cricket and ClimateBritain’s Prince William and Kate Middleton began a three-day visit to India with a game of street cricket…
-
L’Oreal US settles hair relaxer cancer cases during first trial
-
Volition expands Fujifilm deal to include feline cancer test
-
Cardiff Oncology at UBS conference: phase iii push gains speed
-
Relmada at Jefferies conference: bladder cancer bet gains focus
-
Summit Therapeutics stock plunges after FDA rejects lung cancer drug
2 sources · Investing.com, NDTV Profit